13.3.2026 – UMBI Research Updates Series (RUS) in Molecular Medicine
13 March 2026 – ๐๐๐๐ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐ฉ๐๐๐ญ๐ ๐๐๐ซ๐ข๐๐ฌ ๐ข๐ง ๐๐จ๐ฅ๐๐๐ฎ๐ฅ๐๐ซ ๐๐๐๐ข๐๐ข๐ง๐ ๐๐จ.๐/๐๐๐๐ featured two UMBI Research Fellows presenting their latest research in cancer biology and infectious disease genomics earlier this morning.
ย
๐๐ซ. ๐๐ณ๐๐ง๐๐ ๐๐ณ๐ฅ๐ข๐ง๐ ๐๐จ๐ก๐ ๐๐๐ง๐ข๐ presented a talk titled โ๐
๐ซ๐จ๐ฆ ๐๐๐๐ฎ๐ญ๐ญ๐๐ฅ ๐ญ๐จ ๐๐๐ฌ๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง: ๐๐ง๐๐จ๐ฏ๐๐ซ๐ข๐ง๐ ๐๐ง๐ญ๐ซ๐-๐๐ฎ๐ฆ๐จ๐ซ๐๐ฅ ๐๐๐
ฮฒ ๐๐ฌ๐จ๐๐จ๐ซ๐ฆ ๐๐ฒ๐ง๐๐ฆ๐ข๐๐ฌ ๐ข๐ง ๐๐๐๐.โ Her presentation explored the complex regulatory roles of transforming growth factor beta (TGFฮฒ) isoforms within the tumour microenvironment of triple-negative breast cancer (TNBC). She highlighted how the dynamic interplay of TGFฮฒ isoforms contributes to tumour progression and therapeutic response, offering insights that may inform future strategies for targeted treatment in aggressive breast cancer subtypes.
ย
๐๐ซ. ๐๐จ๐ซ ๐๐ณ๐ข๐ฅ๐ ๐๐ฎ๐ก๐๐ฆ๐ฆ๐๐ ๐๐ณ๐๐ฆ๐ข delivered a presentation titled โ๐๐๐ฌ๐๐ฅ๐ข๐ง๐ ๐๐จ๐ก๐จ๐ซ๐ญ ๐๐ซ๐จ๐๐ข๐ฅ๐: ๐๐ฅ๐ข๐ง๐ข๐๐๐ฅ ๐๐ง๐ ๐๐จ๐ฅ๐๐๐ฎ๐ฅ๐๐ซ ๐๐ก๐๐ซ๐๐๐ญ๐๐ซ๐ข๐ฌ๐๐ญ๐ข๐จ๐ง ๐จ๐ ๐๐๐๐-๐๐จ๐-๐ ๐๐ง๐๐๐๐ญ๐๐ ๐๐๐ญ๐ข๐๐ง๐ญ๐ฌ ๐๐๐๐ซ๐ฎ๐ข๐ญ๐๐ ๐ข๐ง๐ญ๐จ ๐ ๐๐จ๐ง๐ ๐ข๐ญ๐ฎ๐๐ข๐ง๐๐ฅ ๐๐๐๐๐-๐๐ ๐๐จ๐ก๐จ๐ซ๐ญ ๐๐ญ๐ฎ๐๐ฒ (๐๐๐๐๐๐) ๐ข๐ง ๐๐๐ฅ๐๐ฒ๐ฌ๐ข๐.โ She presented findings from the COVGEN study, focusing on risk factors associated with disease outcomes, symptom prevalence, and odds ratios among SARS-CoV-2 infected patients. The presentation also highlighted the attrition rate observed in the longitudinal cohort, providing important context for understanding patient follow-up and data retention in long-term COVID-19 research in Malaysia.
ย
Overall, the session provided valuable insights into ongoing research at UMBI and fostered meaningful knowledge exchange among the research community. ๐๐๐๐ ๐๐ฑ๐ญ๐๐ง๐๐ฌ ๐ข๐ญ๐ฌ ๐๐ฉ๐ฉ๐ซ๐๐๐ข๐๐ญ๐ข๐จ๐ง ๐ญ๐จ ๐๐ฅ๐ฅ ๐ฉ๐๐ซ๐ญ๐ข๐๐ข๐ฉ๐๐ง๐ญ๐ฌ ๐๐จ๐ซ ๐ญ๐ก๐๐ข๐ซ ๐๐ญ๐ญ๐๐ง๐๐๐ง๐๐ ๐๐ง๐ ๐๐๐ญ๐ข๐ฏ๐ ๐๐ง๐ ๐๐ ๐๐ฆ๐๐ง๐ญ ๐ญ๐ก๐ซ๐จ๐ฎ๐ ๐ก๐จ๐ฎ๐ญ ๐ญ๐ก๐ ๐ฌ๐๐ฌ๐ฌ๐ข๐จ๐ง.
—
SDG 4 – Quality Education